Houttuynia cordata Thunb inhibits the production of pro-inflammatory cytokines through inhibition of the NFκB signaling pathway in HMC-1 human mast cells

Molecular Medicine Reports

Volumn 8, Issue 3, 2013, Pages 731-736

  Lee, Hee Joe ^a   Seo, Hye Sook ^b   Kim, Gyung Jun ^a   Jeon, Chan Yong ^a   Park, Jong Hyeong ^a   Jang, Bo Hyoung ^b   Park, Sun Ju ^b   Shin, Yong Cheol ^b   Ko, Seong Gyu ^b  

^a Kyongwon University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Allergic inflammation; Houttuynia cordata Thunb; Human mast cells; NF B; Pro inflammatory cytokine

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIMYCIN; CALCIUM IONOPHORE; CYTOKINE; CYTOPLASM PROTEIN; HERBACEOUS AGENT; HOUTTUYNIA CORDATA EXTRACT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LUCIFERASE; MESSENGER RNA; NUCLEAR PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HOUTTUYNIA CORDATA; HOUTTUYNIA CORDATA THUNB; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CALCIMYCIN; CELL LINE; CELL SURVIVAL; CYTOKINES; HOUTTUYNIA; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-6; INTERLEUKIN-8; MAST CELLS; NF-KAPPA B; PHOSPHORYLATION; PLANT EXTRACTS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881125470     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1585     Document Type: Article

References (35)

1. Ferrero-Miliani L, Nielsen OH, Andersen PS and Girardin SE: Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 147: 227-235, 2007.
2. Rosenwasser LJ: Current understanding of the pathophysiology of allergic rhinitis. Immunol Allergy Clin North Am 31: 433-439, 2011.
3. Rose S, Weld-Moore R, Ghazali N and Newman L: 'I've got hay-fever and my mouth is stinging!'. Br Dent J 211: 369-370, 2011.
4. Olivera A and Rivera J: An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. Adv Exp Med Biol 716: 123-142, 2011.
5. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ and Kaplan AP: Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 175: 489-493, 1992.
6. Wang SL, Malany S, Wang Q, Santos MA, Crowe PD and Maki RA: Histamine induces interleukin-6 expression in the human synovial sarcoma cell line (SW982) through the H1 receptor. Inflamm Res 55: 393-398, 2006.
7. Thomas PS: Tumor necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 79: 132-140, 2001.
8. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M and Galli SJ: Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci USA 102: 6467-6472, 2005.
9. Bodreau RT, Hoskin DW and Lin TJ: Phosphatase inhibition potentiates IL-6 production by mast cells in response to FcepsilonRI-mediated activation: involvement of p38 MAPK. J Leukoc Biol 76: 1075-1081, 2004.
10. Murayama T, Mukaida N, Sadanari H, Yamaguchi N, Khabar KS, Tanaka J, Matsushima K, Mori S and Eizuru Y: The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression. Biochem Biophys Res Commun 279: 298-304, 2000.
11. Kuprsh DV, Udalova IA, Turetskaya RL, Rice NR and Nedospasov SA: Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene 11: 97-106, 1995.
12. Galien R, Evans HF and Garcia T: Involvement of CCAAT/ enhancer-binding protein and nuclear factor-kappa B binding site in interleukin-6 promoter inhibition by estrogens. Mol Endocrinol 10: 713-722, 1996.
13. Chang JS, Chiang LC, Chen CC, Liu LT, Wang KC and Lin CC: Antileukemic activity of Bidens pilosa L. var. minor (Blume) Sherff and Houttuynia cordata Thunb. Am J Chin Med 29: 303-312, 2001.
14. Chiang LC, Chang JS, Chen CC, Ng LT and Lin CC: Anti-herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am J Chin Med 31: 355-362, 2003.
15. Li GZ, Chai OH, Lee MS, Han EH, Kim HT and Song CH: Inhibitory effects of Houttuynia cordata water extracts on anaphylactic reaction and mast cell activation. Biol Pharm Bull 28: 1864-1868, 2005.
16. Lu HM, Liang YZ, Yi LZ and Wu XJ: Anti-inflammatory effect of Houttuynia cordata injection. J Ethnopharmacol 104: 245-249, 2006.
17. Chen YY, Liu JF, Chen CM, Chao PY and Chang TJ: A study of the antioxidative and antimutagenic effects of Houttuynia cordata Thunb. using an oxidized frying oil-fed model. J Nutr Sci Vitaminol (Tokyo) 49: 327-333, 2003.
18. Kim IS, Kim JH, Kim JS, Yun CY, Kim DH and Lee JS: The inhibitory effect of Houttuynia cordata extract on stem cell factor-induced HMC-1 cell migration. J Ethnopharmacol 112: 90-95, 2007.
19. Lee JS, Kim IS, Kim JH, Kim JS, Kim DH and Yun CY: Suppressive effects of Houttuynia cordata Thunb (Saururaceae) extract on Th2 immune response. J Ethnopharmacol 117: 34-40, 2008.
20. Tang YJ, Yang JS, Lin CF, Shyu WC, Tsuzuki M, Lu CC, Chen YF and Lai KC: Houttuynia cordata Thunb extract induces apoptosis through mitochondrial- dependent pathway in HT-29 human colon adenocarcinoma cells. Oncol Rep 22: 1051-1056, 2009.
21. Bischoff SC: Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 7: 93-104, 2007.
22. Mekori YA and Metcalfe DD: Mast cells in innate immunity. Immunol Rev 173: 131-140, 2000.
23. Prussin C and Metcalfe DD: 4. IgE, mast cells, basophils and eosinophils. J Allergy Clin Immunol 111 (2 Suppl): S486-S494, 2003.
24. Kim SJ, Lee EJ, Song YS, Jeong HJ, Lee KM, Kim HR, Chae HJ, Shin TY, Kim YK, Hong SH and Kim HM: Cheongyeolsaseuptang inhibits production of TNF-alpha, IL-6 and IL-8 as well as NF-kappa B activation in human mast cells. J Ethnopharmacol 97: 83-88, 2005.
25. Cha JY, Jung JY, Jung JY, Lee JR, Cho IJ, Ku SK, Byun SH, Ahn YT, Lee CW, Kim SC and An WG: Inhibitory effects of traditional herbal formula pyungwi-san on inflammatory response in vitro and in vivo. Evid Based Complement Alternat Med 2013: 630198, 2013.
26. Kim SR, Choi HS, Seo HS, Choi YK, Shin YC and Ko SG: Topical application of herbal mixture extract inhibits ovalbumin-or 2,4-dinitrochlorobenzene-induced atopic dermatitis. Evid Based Complement Alternat Med 2012: 545497, 2012.
27. Park E, Kum S, Wang C, Park SY, Kim BS and Schuller-Levis G: Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. Am J Chin Med 33: 415-424, 2005.
28. Harada M, Nagata M and Takeuchi M: Production of passive cutaneous anaphylaxis (PCA) and reversed PCA by rat IgE antibody in the mouse. Experientia 44: 459-462, 1988.
29. Valenta R: The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2: 446-453, 2002.
30. Galli SJ, Tsai M and Piliponsky AM: The development of allergic inflammation. Nature 454: 445-454, 2008.
31. Lippert U, Möller A, Welker P, Artuc M and Henz BM: Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol 9: 118-124, 2000.
32. Cruse G, Kaur D, Yang W, Duffy SM, Brightling CE and Bradding P: Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 25: 858-863, 2005.
33. Choi IW, Kim YS, Kim DK, Choi JH, Seo KH, Im SY, Kwon KS, Lee MS, Ha TY and Lee HK: Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. J Exp Med 198: 145-151, 2003.
34. Mohamed MR and McFadden G: NFkB inhibitors: strategies from poxviruses. Cell Cycle 8: 3125-3132, 2009.
35. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145, 2001.